vorsetuzumab mafodotin antibodydrug conjugate adc directed protein designed treatment humanized monoclonal antibody vorsetuzumab conjugated noncleavable monomethyl auristatin f mmaf cytotoxic agentcitation needed drug developed seattle genetics inc drug completed phase clinical trials renal cell development discontinued reason given sg plan start clinical trials monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikivorsetuzumabmafodotin